Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
An overview of the molecular mechanisms and novel roles of Nrf2 in neurodegenerative disorders.
Natural Killer Cell Subsets in Cerebrospinal Fluid of Patients with Multiple Sclerosis.
Further evidence for the neuroprotective role of oleanolic acid in a model of focal brain hypoxia in rats.
Estimated Prevalence and Incidence of Multiple Sclerosis in Iran.
Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein.
Production and use of lentivirus to selectively transduce primary oligodendrocyte precursor cells for in vitro myelination assays.
Cognitive and White Matter Tract Differences in MS and Diffuse Neuropsychiatric Systemic Lupus Erythematosus.
Stoppers and non-starters of disease-modifying treatment in multiple sclerosis.
Expression of Lymphatic Markers in the Adult Rat Spinal Cord.
Vitamin D supplementation and antibodies against the Epstein-Barr virus in multiple sclerosis patients.
The secretome of mesenchymal stem cells: Potential implications for neuroregeneration.
Quantifying gait impairment using an instrumented treadmill in people with multiple sclerosis.
Sporadic Porphyria Cutanea Tarda in a Patient with Multiple Sclerosis Treated with Interferon Beta 1-a Therapy: A Case Report.
"Optic neuritis" that is neither.
Magnetic resonance monitoring of lesion evolution in multiple sclerosis.
OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Activity Regardless of Concomitant Anticholinergic Use or Neurologic Etiology.
Multiple sclerosis: Scoring system to predict response to IFN-β in patients with multiple sclerosis.
The role of neurotrophins in multiple sclerosis-pathological and clinical implications.
Disability caused by multiple sclerosis is associated with the number of extra cranial venous stenoses: possible improvement by venous angioplasty. Results of a prospective study.
Chronic cerebrospinal venous insufficiency is not associated with multiple sclerosis and its severity: a blind-verified study.
Role of puberty in multiple sclerosis risk and course.
Effects of long-term whole-body vibration training on mobility in patients with multiple sclerosis: A meta-analysis of randomized controlled trials.
Nogo Receptor Signaling Restricts Adult Neural Plasticity by Limiting Synaptic AMPA Receptor Delivery.
Role of Rho Kinase and Fasudil on Synaptic Plasticity in Multiple Sclerosis.
Improving multiple sclerosis care: an analysis of the necessity for medication therapy management services among the patient population.
Pages
« first
‹ previous
…
501
502
503
504
505
506
507
508
509
…
next ›
last »